Multicomponent Lifestyle Intervention and Brain Aging
JAMA Network Open · 18.11.2026 · 9 (11) · e2644426
DOI: 10.1001/jamanetworkopen.2026.44426 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 18.11.2026. Verfasst von F. Vankee-Lin und 7 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Importance Multicomponent lifestyle interventions show promise for promoting cognitive health, but their effects on clinically established brain aging markers among individuals with amnestic mild cognitive impairment (aMCI) are unclear. Intervention adherence may influence intervention efficacy.
Objectives
To evaluate the association of combined aerobic exercise and cognitive training (ACT) with brain aging markers and to explore the role of intervention adherence. Design, Setting, and Participants This secondary analysis of a phase 2, single-blind, 2 × 2 factorial randomized clinical trial with data collection lasting up to 18 months per participant was conducted at 3 academic research facilities between April 1, 2018, and July 17, 2024. Among 911 individuals screened, 146 participants with aMCI were randomized. Data were analyzed from October 10, 2025, to January 8, 2026.
Interventions
The ACT intervention was compared with 3 other intervention arms during a 6-month period, including speed-of-processing training (SOP), cycling, and mental leisure activities plus stretching (MS). Main Outcomes and Measures Alzheimer disease signature for cortical thickness (ADSCT) and natural log–transformed white matter hyperintensity (ln-WMH) were assessed at baseline, post intervention, and at the 12- and 18-month follow-ups. Outcome-specific modified intention-to-treat analyses used 100 forward-only multiple imputations and age-, sex-, and site-adjusted linear mixed-effects models with a participant random intercept. Visit-specific complete-case and attendance analyses used participants observed at baseline and the relevant follow-up.
Results
Among 146 randomized participants (mean [SD] age, 73.8 [5.7] years), 75 (51.4%) were male. A total of 144 participants had baseline ADSCT and 141 had baseline ln-WMH measurements. In primary analyses, compared with ACT, SOP was associated with greater worsening in 18-month ADSCT change (B = −0.060 [95% CI, −0.117 to −0.004] mm; P = .04), and MS was associated with greater 12-month worsening (B = −0.066 [95% CI, −0.122 to −0.011] mm; P = .02). No primary ln-WMH contrast was significant. In visit-specific complete cases, cycling was associated with greater 18-month ln-WMH progression than ACT (B = 0.452 [95% CI, 0.131-0.772] natural log units; P = .006). Exploratory within-ACT analyses linked each of 10 additional sessions to greater postintervention ADSCT change (B = 0.022 [95% CI, 0.002-0.042] mm; P = .03), but not ln-WMH change. Conclusions and Relevance In this secondary analysis of a randomized clinical trial of older adults with aMCI, ACT was associated with more favorable ADSCT change than SOP at 18 months and MS at 12 months. No primary ln-WMH contrast was significant. Attendance findings were post randomization and exploratory. Larger confirmatory trials are needed to verify these findings. Trial Registration ClinicalTrials.gov Identifier: NCT03313895
Zitieren
APA
Vankee-Lin, F., Ai, M., Zhuang, Y., Heffner, K. L., Salisbury, D., Li, D., Jack, C. R., & Yu, F. (2026). Multicomponent Lifestyle Intervention and Brain Aging. JAMA Network Open, 9(11), e2644426. https://doi.org/10.1001/jamanetworkopen.2026.44426
Vancouver
Vankee-Lin F, Ai M, Zhuang Y, Heffner KL, Salisbury D, Li D, et al. Multicomponent Lifestyle Intervention and Brain Aging. JAMA Network Open. 2026;9(11):e2644426. doi:10.1001/jamanetworkopen.2026.44426
BibTeX
@article{VankeeLin2026,
author = {Vankee-Lin, F. and Ai, Meishan and Zhuang, Yuchuan and Heffner, Kathi L. and Salisbury, Dereck and Li, Danni and Jack, Clifford R. and Yu, Fang},
title = {Multicomponent Lifestyle Intervention and Brain Aging},
journal = {JAMA Network Open},
year = {2026},
volume = {9},
number = {11},
pages = {e2644426},
doi = {10.1001/jamanetworkopen.2026.44426}
}
EUVIMED